$DK

Sutil Vicky sold $141K of DK

Sutil Vicky sold 3,061 shares of Delek US Holdings, Inc. (DK) at $46.00 ($0.14M total) on 2026-06-01.

Original reporting
SEC EDGAR · Sutil Vicky
Published Jun 3, 2026, 12:47 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 1:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DK
Bearish
medium confidence
Mentioned
$DK
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DKBearishLow
01

Why it matters

Traders may monitor for whether this is part of broader insider selling or coincides with other negative company signals, but this filing alone is not a fundamental catalyst.

02

Market read

Provides a small, sentiment-oriented datapoint for DK; no direct link to earnings, guidance, or corporate actions.

03

What to watch

No disclosure of motives, and the absence of a stated 10b5-1 plan does not automatically imply information-driven trading; also, one sale is not a trend.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-02; sale dated 2026-06-01.

Background

The article is an SEC Form 4 insider transaction disclosure (director sale) for Delek US Holdings, Inc.

Company-level read

Ticker impact

$DKBearishMedium confidence
Context

Delek US Holdings director Sutil Vicky sold 3,061 shares in an open-market transaction for ~$140.8K, disclosed via SEC Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small unless follow-on selling appears.

Evidence & confidence

This is a single director sale with no 10b5-1 plan cited and no accompanying company-specific news (earnings, guidance, deal, or investigation).

Market effects

Minimal; insider Form 4 for one issuer typically does not reset sector expectations.

None indicated; transaction is company-specific.

None indicated.

Counterpoint

A director sale can be routine liquidity/portfolio rebalancing and may not reflect bearish fundamentals, especially without additional context.

Key entities

  • Delek US Holdings, Inc.

    Subject of the insider transaction disclosure; director sold shares on 2026-06-01.

  • Sutil Vicky

    Director who executed the open-market sale of 3,061 shares.

Related articles

$DKMedAI 8/10

Delek US Holdings (DK) Q2 2026 Earnings Call Transcript

Delek US Holdings (DK) reported Q2 2026 net income of $170 million ($2.71/share) and adjusted net income of $344 million ($5.48/share). Adjusted EBITDA was $639 million, with RVO-adjusted EBITDA of $490 million and RVO-adjusted EPS of $3.64. Logistics segment adjusted EBITDA was a record $144 million. DKL full-year 2026 EBITDA guidance is $520 million to $560 million.

$DKMed

Delek Slides on Q2 Results

Delek US Holdings (NYSE: DK) reported Q2 ended June 30, 2026 net income of $169.5M ($2.71/share) and adjusted net income of $343.9M ($5.48/share). Adjusted EBITDA was $638.7M; excluding RVO impacts, adjusted EPS was $3.64 and adjusted EBITDA $490.1M. Delek Logistics posted adjusted EBITDA of $143.5M and is targeting $520-560M. Delek bought $20M of DK shares and paid $15.6M in dividends, declaring a $0.255 quarterly dividend.

$DKMedAI 8/10

This is Why Delek US Holdings, Inc. (DK) is One of the Best Oil Stocks to Buy Amid US-Iran War

Delek US Holdings (NYSE:DK) said on April 29 it is improving cash flow via its Enterprise Optimization Plan. In Q1, it completed the Big Spring refinery turnaround on time and on budget and continued ramp-up of the Delaware basin Libby 2 sour gas plant. Adjusted net income was $4.7M ($0.08/share) and adjusted EBITDA $211.7M. Revenue was $2.65B vs $2.42B expected; it ended with $624.1M cash and $3.18B long-term debt.